Actively Recruiting
Percutaneous Transcatheter Genicular Embolization in Osteoarthritis
Led by Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. · Updated on 2026-02-04
20
Participants Needed
1
Research Sites
199 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical study investigates a minimally invasive treatment called percutaneous transcatheter embolization of knee arteries for patients with chronic knee pain caused by advanced knee osteoarthritis or persistent pain after total knee replacement. Osteoarthritis of the knee is a common degenerative condition that can lead to long-term pain, reduced mobility, and decreased quality of life, and some patients do not achieve sufficient relief with standard treatments. The study is based on the hypothesis that targeted embolization of small arteries supplying the inflamed tissues of the knee can safely reduce abnormal blood flow associated with inflammation, leading to pain relief and improved knee function. During the procedure, a thin catheter is guided through the blood vessels to the affected area of the knee, where a temporary embolic agent is administered to reduce pathological blood supply. The aim of the study is to evaluate the safety and effectiveness of this procedure by assessing changes in pain intensity, knee function, and quality of life over a follow-up period of up to 24 months. The results of this study may help determine whether this minimally invasive approach can offer a new treatment option for patients who have limited alternatives for managing chronic knee pain
CONDITIONS
Official Title
Percutaneous Transcatheter Genicular Embolization in Osteoarthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 40 to 80 years
- Chronic knee pain symptoms
- Radiographically confirmed knee osteoarthritis grade II-IV or persistent pain after total knee replacement
- Insufficient pain relief from standard conservative treatments
- Ability to understand and consent to study procedures
- Willingness and ability to follow study schedule and procedures
You will not qualify if you...
- Active local or systemic infection
- Known coagulation disorders or anticoagulation that cannot be safely stopped
- Significant peripheral arterial disease in lower limbs
- Allergy or contraindication to iodinated contrast agents
- Severe kidney impairment
- History of fibromyalgia or other chronic pain syndromes
- Pregnancy or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Masarykova nemocnice v Ústí nad Labem
Ústí nad Labem, Czechia, 40011
Actively Recruiting
Research Team
P
Patrik Matras, MUDr.
CONTACT
P
Pavol Viglas
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here